Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA   US04033A1007

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/26/2015 01/27/2015 01/28/2015 01/29/2015 01/30/2015 Date
6.37(c) 6.46(c) 6.55(c) 6.44(c) 6.46 Last
3 759 377 4 179 635 8 499 633 4 229 318 1 015 808 Volume
+4.43% +1.41% +1.39% -1.68% +0.31% Change
More quotes
Company
ARIAD Pharmaceuticals, Inc. operates as a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.The company has four products: Ridaforolimus, Ponatinib, AP1903 and AP26113.Its approach to structure-based drug... 
Sector
Pharmaceuticals
Calendar
02/24Earnings Release
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 73,6 M
EBIT 2014 -188 M
Net income 2014 -193 M
Finance 2014 160 M
Yield 2014 -
Sales 2015 163 M
EBIT 2015 -136 M
Net income 2015 -139 M
Finance 2015 123 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 14,2x
EV / Sales 2015 6,65x
Capitalization 1 206 M
More Financials
Latest news on ARIAD PHARMACEUTICALS, INC
01/29 ARIAD PHARMACEUTICALS : to Webcast Conference Call on Fourth Quarter and Year-En..
01/29 ARIAD PHARMACEUTICALS : Announces Final Decision from European Commission Endors..
01/23 ARIAD PHARMACEUTICALS : Announces Key Strategic Objectives for 2015 Expected to ..
01/22 ARIAD PHARMACEUTICALS : Announces Appointment of Thomas J. DesRosier, Senior Pha..
01/21 ARIAD PHARMACEUTICALS : Details Strategic Objectives for 2015
01/20 ARIAD PHARMACEUTICALS : Announces Final Decision from European Commission Endors..
01/18 ARIAD PHARMACEUTICALS : Initiates Start of Phase 2 Dose-Ranging Trial of Iclusig..
01/16 ARIAD PHARMACEUTICALS : Details Strategic Objectives for 2015
More news
Sector news Biopharmaceuticals
11:59a OPKO HEALTH : Submits Investigational New Drug Application to Initiate a Phase 2..
10:46a PACCAR : S&P 500 Movers: PCAR, BIIB
10:46a NASDAQ 100 MOVERS : Pcar, amzn
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF